Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo

References

• ChengTYCrambSMBaadePDYouldenDRNwoguCReidMEThe International epidemiology of lung cancer: latest trends, disparities, and tumor characteristicsJ Thorac Oncol201611101653167127364315
   PubMed Web of Science ®Google Scholar
• KawaguchiTKohYAndoMProspective analysis of oncogenic driver mutations and environmental factors: Japan molecular epidemiology for lung cancer studyJ Am Soc Clin Oncol2016341922472257
   PubMedGoogle Scholar
• MolinaJRYangPCassiviSDSchildSEAdjeiAANon-small cell lung cancer: epidemiology, risk factors, treatment, and survivorshipMayo Clin Proc200883558459418452692
   PubMed Web of Science ®Google Scholar
• DidkowskaJWojciechowskaUMańczukMŁobaszewskiJLung cancer epidemiology: contemporary and future challenges worldwideAnn Transl Med20164815027195268
   PubMed Web of Science ®Google Scholar
• HoffmanPCMauerAMVokesEELung cancerLancet2000355920247948510841143
   PubMed Web of Science ®Google Scholar
• SarihanSKayisogullariUErcanIEnginKRandomized phase 2 study of radiotherapy alone versus radiotherapy with paclitaxel in non-small cell lung cancerJ Int Med Res200432437538315303768
   PubMedGoogle Scholar
• SparanoJAJWangMMartinoSWeekly paclitaxel in the adjuvant treatment of breast cancerJ Evid-Based Med20093593310
   Google Scholar
• FujiiTTachibanaMDharDKCombination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in miceAnticancer Res2003233B2405241112894521
   PubMedGoogle Scholar
• WuZHLuMKHuLYLiXZhWLyHUPraziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growthPLoS One2012712e5172123251610
   PubMedGoogle Scholar
• de SouzaRZahediPAllenCJPiquette-MillerMPolymeric drug delivery systems for localized cancer chemotherapyDrug Deliv201017636537520429844
   PubMed Web of Science ®Google Scholar
• Mora-HuertasCEFessiHElaissariAPolymer-based nanocapsules for drug deliveryInt J Pharm20103851–211314219825408
   PubMed Web of Science ®Google Scholar
• YadavAKAgarwalARaiGDevelopment and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracilDrug Deliv201017856157220738221
   PubMed Web of Science ®Google Scholar
• YangBNiXChenLHonokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinomaDrug Deliv201724166066928368206
   PubMed Web of Science ®Google Scholar
• XiCChaoLKaijiangLThe research on functional mechanism of timely chemotherapyMod Prev Med2008352201202
   Google Scholar
• JunquanYLipingLRuijuanZPerlimary results of concurrent three-dimenonal conformal radio therapy combined with Chronochemotrapy for advanced non-small cell lung cancerMod Prev Med200633712831291
   Google Scholar
• YufengLJunYCompare the categories and extents of toxic and side-effect of time chemothrapy and routine chemothrapyFront Med2011121138140
   Google Scholar
• TaharaYOtsukaMFuseYHiraoAShibataSRefeeding after fasting elicits insulin-dependent regulation of Per2 and REV-ERBα with shifts in the liver clockJ Biol Rhythms201126323024021628550
   PubMed Web of Science ®Google Scholar
• LéviFFilipskiEIurisciILiXMInnominatoPCross-talks between circadian timing system and cell division cycle determine cancer biology and therapeuticsCold Spring Harb Symp Quant Biol200772146547518419306
   PubMedGoogle Scholar
• TsimakouridzeEVAlibhaiFJMartinoTATherapeutic applications of circadian rhythms for the cardiovascular systemFront Pharmacol201567725941487
   PubMed Web of Science ®Google Scholar
• RoennebergTDaanSMerrowMThe art of entrainmentJ Biol Rhythms200318318319412828276
   PubMed Web of Science ®Google Scholar
• ZhangYHZhaoGFYinKFThe expression and clinical significance of β-galactose lectin 3 and clock genes Per2 in non-small cell lung cancerChinese J Heal Lab Tech2014241826922694
   Google Scholar
• YangXWoodPAOhEYDu-QuitonJAnsellCMHrusheskyWJDown regulation of circadian clock gene period 2 accelerates breast cancer growth by altering its daily growth rhythmBreast Cancer Res Treat2009117242343118651214
   PubMed Web of Science ®Google Scholar
• HuJFuSPengQPaclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: in vitro and in vivo evaluationInt J Pharm20175161–231332227884713
   PubMedGoogle Scholar
• ParkCWBakYKimMJThe novel small molecule STK899704 promotes senescence of the human A549 NSCLC cells by inducing DNA damage responses and cell cycle arrestFront Pharmacol2018916329713275
   PubMedGoogle Scholar
• GadgeelSMPersonalized therapy of non-small cell lung cancer (NSCLC)Adv Exp Med Biol2016890320326703806
   PubMedGoogle Scholar
• HopeWWBoltonWDKalbaughCABlackhurstDWStephensonJETaylorSMLung cancer resection in octogenarians: a reasonable approach for our aging populationAm Surg20077312217249451
   PubMedGoogle Scholar
• FringsSNew molecular targeted therapeutic drugs clinical results of bevacizumab in non-small cell lung cancer (NSCLC)Haigan2006463277281
   Google Scholar
• AbbasiSBadheebAPrognostic factors in advanced non-small-cell lung cancer patients: patient characteristics and type of chemotherapyLung Cancer Int20112011414
   Google Scholar
• HuangCYJuDTChangCFMuralidhar ReddyPVelmuruganBKA review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancerBiomedicine2017742329130448
   PubMedGoogle Scholar
• ChenKShiWAutophagy regulates resistance of non-small cell lung cancer cells to paclitaxelTumor Biol20163781053910544
   PubMedGoogle Scholar
• CoynePJWanWDodsonPSwaineyCSmithTJA trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathyJ Pain Palliat Care Pharmacother201327435936424143893
   PubMedGoogle Scholar
• WangTHWangHSSoongYKPaclitaxel-induced cell death: Where the cell cycle and apoptosis come togetherCancer200088112619262810861441
   PubMed Web of Science ®Google Scholar
• ChangYFLiLLWuCWPaclitaxel-induced apoptosis in human gastric carcinoma cell linesCancer199677114188630921
   PubMed Web of Science ®Google Scholar
• Morales-CanoDCalviñoERubioVApoptosis induced by paclitaxel via Bcl-2, BAX and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibitionExp Toxicol Pathol2013657–81101110823735541
   PubMedGoogle Scholar
• Salah-EldinAEInoueSTsukamotoSAoiHTsudaMAn association of Bcl-2 phosphorylation and Bax localization with their functions after hyperthermia and paclitaxel treatmentInt J Cancer20031031536012455053
   PubMed Web of Science ®Google Scholar
• YangXWoodPAAnsellCMThe circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of dayChronobiol Int20092671323133919916834
   PubMed Web of Science ®Google Scholar
• ZhaoNYangKYangGAberrant expression of clock gene Period1 and its correlations with the growth, proliferation and metastasis of buccal squamous cell carcinomaPLoS One201382e5589423405233
   PubMed Web of Science ®Google Scholar
• XuYTohKLJonesCRShinJYFuYHPtácekLJModeling of a human circadian mutation yields insights into clock regulation by PER2Cell20071281597017218255
   PubMedGoogle Scholar
• SuXChenDYangKThe circadian clock gene PER2 plays an important role in tumor suppression through regulating tumor-associated genes in human oral squamous cell carcinomaOncol Rep201738147248028535015
   PubMedGoogle Scholar
• ChenSTChooKBHouMFYehKTKuoSJChangJGDeregulated expression of the PER1, PER2 and PER3 genes in breast cancersCarcinogen200526712411246
   PubMed Web of Science ®Google Scholar
• WinterSLBosnoyan-CollinsLPinnaduwageDAndrulisILExpression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumorsNeoplasia200791079780017971899
   PubMed Web of Science ®Google Scholar